Stock Events

Stock Events

Actuate Therapeutics (ACTU) Q1 2026 Earnings

26MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.32

-0.28

-0.24

-0.2

Details

Expected EPS

-0.244167

Actual EPS

-0.2

Surprise EPS

0.04

Surprise Percent

+18.09%

Description

Actuate Therapeutics (ACTU) has reported earnings of -0.2 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.